Biomune is classified as operating in the Biological Product Manufacturing industry, NAICS Code 325414.
Trademark Applications
Trademark applications show the products and services that Biomune is developing and marketing.
Biomune doesn't have any recent trademark applications, indicating Biomune is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SALMUNE Veterinary vaccine used for the prevention of salmonella infection in poultry, birds and animals, namely, swine, cattle, horses and dogs
07/12/2022
LAYERMUNE veterinary vaccines for poultry containing Salmonella Enteritidis
12/01/2020
UNITED Animal vaccines
10/15/2014
See all trademarks and details in the Full Report.
Market Share of Biomune's Largest Competitors
A competitive analysis shows these companies are in the same general field as Biomune, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Biomune.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Biomune and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.